Japan's Financial Services Agency has added a small but operationally useful Q&A to its capital adequacy rules. The note, added on May 25, says that when a borrower grants corporate value collateral, meaning collateral over the borrower's total asset pool, banks may in some cases recognize the credit risk mitigation effect of qualifying collateral sitting inside that pool. In the same attachment, the agency says exposures insured by NEXI can be treated under the standardized approach as exposures benefiting from a government guarantee.
Standardized approach: possible recognition, not automatic recognition
For banks using the standardized approach, the FSA says institutions still need a case-by-case judgment on whether the relevant item meets the regulatory definitions and requirements for qualifying financial collateral. If a bank wants to reflect the mitigation effect of qualifying financial collateral inside a corporate value collateral package, it must be able to explain to supervisors how the relevant security interests are maintained. It also needs arrangements to check whether those measures remain effective and whether they need to be revised. In other words, the collateral can count, but only if the paperwork and control framework are more than decorative.
The separate answer on NEXI is cleaner. Citing Article 28 of the Trade Insurance Act, the FSA says the law provides for necessary fiscal measures within the budget if NEXI has difficulty raising funds, so that insurance claims can be paid reliably. On that basis, exposures carrying NEXI insurance may be treated, through Article 129(2)'s application of Article 129(1), as receiving a government guarantee.
IRB approach: broader collateral menu
In the internal ratings-based section, the FSA makes a similar clarification but with a wider set of qualifying assets. It says firms should judge case by case whether items inside the corporate value collateral package qualify as either eligible financial collateral or eligible asset collateral. If they do, the credit risk mitigation effect may be taken into account. The same supervisory burden remains: firms need measures to maintain the relevant security interests, plus a framework for checking whether those measures are effective and whether review is needed.
For risk, regulatory reporting and trade-finance teams, the practical point is straightforward. This Q&A does not make every enterprise-wide pledge or every insurance policy capital-friendly. It does tell banks where the FSA is prepared to recognize collateral or insurance effects within the existing rulebook, and where governance will decide whether a firm can support that treatment to supervisors. The FSA page also carries a machine-translation disclaimer, so institutions will want to check the Japanese wording closely before rewriting policy manuals or model documentation, especially around the difference between the standardized and IRB treatments.